-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
background
Background backgroundTwo randomized controlled trials have shown that tocilizumab has the effect of reducing the use of glucocorticoids in patients with giant cell arteritis
Two randomized controlled trials have shown that tocilizumab has the effect of reducing the use of glucocorticoids in patients with giant cell arteritis
method
Method methodThe researcher-initiated, single-arm, single-center, open-label, proof-of-concept test, using a Simon two-stage design, was completed at the Bern University Hospital in Bern, Switzerland
The researcher-initiated, single-arm, single-center, open-label, proof-of-concept test, using a Simon two-stage design, was completed at the Bern University Hospital in Bern, Switzerland
Result result
From 2018 Nian 11 Yue 23 Ri to 2019 Nian 9 Yue 22 days, recruited 18 patients (of which 12 are women, 18 per capita is white), the median age was 72 (IQR 67-75) years old
From 2018 Nian 11 Yue 23 Ri to 2019 Nian 9 Yue 22 days, recruited 18 patients (of which 12 are women, 18 per capita is white), the median age was 72 (IQR 67-75) years old
Meaning meaning
Data show that in newly diagnosed patients with giant cell arteritis, tocilizumab has a slow induction of remission and a long-lasting remission maintenance effect after ultrashort pulses of glucocorticoids
Data show that in newly diagnosed patients with giant cell arteritis, tocilizumab has a slow induction of remission and a long-lasting remission maintenance effect after ultrashort pulses of glucocorticoids
Reference:
Lisa Christ, Luca Seitz, Godehard Scholz, Adela-Cristina Sarbu, Jennifer Amsler, Lukas Bütikofer, Christoph Tappeiner, Florian Kollert, Stephan Reichenbach, Peter M Villiger .
Lisa Christ, Luca Seitz, Godehard Scholz, Adela-Cristina Sarbu, Jennifer Amsler, Lukas Bütikofer, Christoph Tappeiner, Florian Kollert, Stephan Reichenbach, Peter M Villiger .
Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm arteritis , open-label, proof-of-concept study.
Lancet Rheumatol.
2021 July 02.
https://doi.
org/10.
1016/S2665-9913(21)00152-1 .
https://doi.
org/10.
1016/S2665 -9913(21)00152-1
leave a message here
